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Abstract
Mastitis or other infectious diseases have been related to reduced fertility in cattle. Inflammatory cytokines such as
tumor necrosis factor a (TNFa) are released in response to infection and may have negative effects on embryo
development. In the current study the effect of exposure to TNFa on the development of in vitro fertilized bovine
embryos was examined. Indomethacin, a prostaglandin synthesis inhibitor, was used to determine if blockade of
prostaglandin synthesis would alter the effects of TNFa. Ovaries were obtained from a local abattoir and immature
COC were isolated from 2-10 mm follicles, in vitro matured and fertilized. After fertilization, groups of presumptive
zygotes were randomly placed into either control development medium, medium containing 25 ng/mL TNFa or
medium containing 25 ng/mL TNFa plus 1 μg/mL indomethacin. The proportion of blastocysts formed was
assessed at day 7 of culture. Fewer embryos exposed to TNFa alone reached the blastocyst stage (17.5 ± 2.4%, P <
0.01) compared with controls (30.5 ± 2.4%) or embryos developed in TNFa plus indomethacin (25.8 ± 2.8%). There
was no difference between control embryos and embryos developed in TNFa plus indomethacin. These results
indicate that TNFa is inhibitory to the in vitro development of bovine embryos and that this inhibition may be
mediated by prostaglandins because it can be blocked by indomethacin.
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Background
Mastitis and other inflammatory diseases occur in cattle
leading to not only decreased milk production and
increased costs but to a reduction in reproductive per-
formance [1,2]. Cytokines, such as tumor necrosis factor
a (TNFa), play a role in the immune response and are
increased in the serum of cows diagnosed with clinical
mastitis [2]. This release of cytokines can have detri-
mental effects on endometrial and oviductal tissue lead-
ing to decreased embryo development. Addition of
TNFa to oocyte maturation media in vitro reduced the
development of bovine cumulus oocyte complexes
(COC) to the blastocyst stage [3]. This effect of TNFa
could be mediated by prostaglandins. Cyclo-oxygenase-2
(COX2), an inducible enzyme responsible for the first
step in prostaglandin production from arachidonic acid
is upregulated by cytokines [4]. Exposure of bovine
embryos to prostaglandin F2 a (PGF2a) inhibited devel-
opment to the blastocyst stage in vitro [5] and proges-
terone supplemented cows exposed to PGF2a had
reduced embryo quality [6]. Bovine oocytes expressed
TNFa mRNA and lower TNFa mRNA levels were asso-
ciated with more oocytes developing to the blastocyst
stage on day 8 [7]. The objective of the current experi-
ment was to determine if addition of indomethacin, an
inhibitor of the COX enzyme, could block the detrimen-
tal effects of TNFa on development of bovine embryos.
Materials and methods
Reagents
Tissue culture medium (TCM-199) was purchased from
Gibco-BRL (Grand Island, NY). Fatty-acid free BSA was
purchased from Boehringer-Mannheim (Indianapolis,
IN). Recombinant bovine TNFa was purchased from
Pierce Endogen (Rockford, IL) and reconstituted in ster-
ile saline to a final concentration of 4 ng/mL. All other
reagents and media supplements were of tissue culture
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grade and were obtained from Sigma Chemical Co. (St.
Louis, MO). Indomethacin was reconstituted to a 1000X
stock solution of 1 μg/mL in sterile absolute ethanol.
With the exception of the fertilization medium, all cul-
ture media contained 50 μg/mL of gentamicin.
Maturation, fertilization and development
In vitro maturation (IVM), fertilization (IVF) and devel-
opment (IVD) were performed as the method described
by [8]. Ovaries were collected from open cows (based
on uterine examination) at a local abattoir and trans-
ported to the laboratory in 0.9% saline with 0.75 μg/mL
of penicillin (approximately 2 hours). The ovaries were
washed in sterile saline upon arrival and cumulus-
oocyte-complexes (COCs) were aspirated from 2-10 mm
follicles with an 18 gauge needle and syringe. Immature
COC were selected and moved to a divided petri dish
containing Tyrode medium (TL-Hepes) and washed
four times [9]. The COC were placed in maturation
medium consisting of M199 with 10% FBS supplemen-
ted by 5 μg/mL FSH, 10 μg/mL LH, 1 mg/mL estradiol,
200 μmol/L pyruvate and 50 μg/mL gentamicin for 20 h
at 39°C in 5% CO2. After maturation, COC were washed
and held in fertilization medium containing heparin-
supplemented Tyrodes albumin lactate pyruvate (TALP)
with 6 mg/mL BSA [8].
Frozen/thawed sperm from the same bull were used
for fertilization. Swim-up sperm were collected and used
at a concentration of 0.1 × 106 cell per ml. Gametes
were co-incubated for 18 hs 39°C in 5% CO2. At 18 h
post insemination (hpi) presumptive zygotes were
washed six times in TL-Hepes and approximately 25-30
were randomly distributed to one well of a four well
culture plate containing the development medium with
one of the treatments. All treatments were contained
within development medium containing M199, 10% FBS
and 50 μg/mL of gentamicin 39°C in 5% CO2 and 100%
humidity. Development medium was changed at 48 h
intervals throughout culture.
Treatments included: Control development medium
alone, 25 ng/mL TNFa, 1 μg/mL indomethacin, and 25
ng/mL TNFa plus 1 μg/mL indomethacin. All treat-
ments were replicated four times except indomethacin
alone which was replicated twice. Total number of
oocytes used in the experiment were control (225),
TNFa (232), indomethacin (114) and TNFa plus indo-
methacin (225).
Development of the embryos was checked at 168 and
216 hpi and evaluated for embryo quality grade and
stage of development. Developmental stages were classi-
fied as compact morula, early blastocyst, mid-blastocyst,
expanded blastocyst and hatched blastocyst. The quality
of the embryo was graded as 1 for excellent, 2 for mod-
erate and 3 for poor quality [10].
Statistical analysis
Data for the percent embryos developing to the blasto-
cyst stage were arc-sin transformed and analyzed by one
way ANOVA using PROC GLM of SAS 9.1 (Cary, NC)
with Duncan’s Multiple Range Test used for mean
separation.
Results
In preliminary experiments, bovine presumptive zygotes
were placed into medium containing 0, 10, 25, 50 or
100 ng/mL TNFa and evaluated for development to the
blastocyst stage at 168 hpi (2 replicates, n = 60 embryos
per treatment). Fewer blastocysts developed in the 25
ng/mL (19.6 ± 2.2%) 50 (18.5 ± 2.7%) and 100 (14.1 ±
1.9%) ng/mL treatments than the 0 ng/mL dose group
(27.5 ± 2.6%) so the 25 ng/mL dose was chosen for sub-
sequent experiments as the lowest effective dose. The 1
μg/mL dose of indomethacin was tested in two repli-
cates in the system and had no effect by itself on the
percentage of embryos reaching the blastocyst stage
(control 25.2 ± 2.1% vs. indomethacin 25.6 ± 2.4%). As
ethanol was used for the vehicle for indomethacin, abso-
lute ethanol was tested in two replicates and had no
effect on development to the blastocyst stage at 168 hpi
at the concentration used (29.7 ± 2.3% control vs. 30.4
± 2.2% ethanol).
Treatment with 25 ng/mL TNFa reduced the percen-
tage of bovine embryos reaching the blastocyst stage at
168 hpi (17.2 ± 2.4%) compared to controls (30.2 ±
2.7%) and embryos treated with 25 ng/mL TNFa plus 1
μg/mL indomethacin (25.8 ± 2.3%) (Figure 1). There
were no differences in the percentage of embryos in the
different classifications among the embryos that reached
the blastocyst stage (Table 1).
Figure 1 Comparison of the effects of control medium (CON, 0
ng/mL TNFa, n = 4 replicates, 120 embryos), and addition of
25 ng/mL TNFa (n = 4 replicates, 130 embryos) or 25 ng/mL
TNFa plus 1 ug/mL indomethacin (n = 4 replicates, 130
embryos) to medium on the percentage of bovine embryos
reaching the blastocyst stage at 168 h post-insemination.
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Discussion
Soto et al. [3] reported that exposure to TNFa during
maturation reduced the percentage of bovine oocytes
developing to the blastocyst stage. Exposure of bovine
oocytes to TNFa during IVM induced TNFa mRNA
expression and reduced the number of oocytes develop-
ing to the blastocyst stage on day 8 [7]. Our data are in
agreement with these findings. However Soto et al., [3]
reported that TNFa added to the incubation media
post-fertilization had no effect on the number of oocytes
reaching the blastocyst stage on day 8, an observation
that is in contrast to our findings. The number of apop-
totic cells in blastocysts was increased by incubation
with TNFa [3] suggesting that some detrimental effect
of TNFa was present. Differences in culture media or
conditions may account for contrasting results between
the current experiment and that of Soto et al., [3].
The research presented herein indicates that TNFa
works through the prostaglandins since the inhibitory
effect of TNFa was blocked by co-treatment with indo-
methacin. In previous work [5], PGF added to the devel-
opment medium decreased the percentage of bovine
embryos reaching the blastocyst stage. On day 7 bovine
blastocysts expressed the COX2 gene and TNFa expres-
sion was lower in embryos that went on to produce a
pregnancy [11] Furthermore, treatment with flunixin
meglumine, another prostaglandin synthesis inhibitor,
blocked the detrimental effects of oxytocin administra-
tion on bovine embryo [12] and addition of a prosta-
glandin receptor antagonist improved bovine embryo
survival [13]. Taken together, these observations support
the suggestion that PGs mediate a detrimental effect on
blastocyst development. In vivo, bovine endometrium
and cumulus cells can produce prostaglandins [14,15].
Production of PGF by the bovine oviduct was increased
by the presence of TNFa [16] but embryos themselves
may also be able to produce PGF in response to TNFa.
The results of the current study support the hypothesis
that the embryo itself is capable of producing prosta-
glandins after exposure to TNFa and that this prosta-
glandin production by the blastocyst is detrimental to
its own development, although some prostaglandins may
be beneficial to embryo development.
Cows with mastitis had higher concentrations of
PGF2a in their milk than cows that did not have masti-
tis [17] Increased prostaglandin production by
blastocysts in response to inflammatory cytokines such
as TNFa may explain the decreased fertility that is com-
monly observed after diseases such as mastitis. Concen-
trations of TNFa used in the current experiment were
higher than those reported in serum of mastitic cows
but levels within the uterus and oviduct are unknown
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